- Home
- SFNC vs OCUL Comparison
SFNC vs OCUL Comparison
Compare SFNC & OCUL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SFNC
- OCUL
- Stock Information
- Founded
- SFNC 1903
- OCUL 2006
- Country
- SFNC United States
- OCUL United States
- Employees
- SFNC N/A
- OCUL N/A
- Industry
- SFNC Major Banks
- OCUL Biotechnology: Pharmaceutical Preparations
- Sector
- SFNC Finance
- OCUL Health Care
- Exchange
- SFNC Nasdaq
- OCUL Nasdaq
- Market Cap
- SFNC 2.2B
- OCUL 1.8B
- IPO Year
- SFNC N/A
- OCUL 2014
- Fundamental
- Price
- SFNC $19.02
- OCUL $11.92
- Analyst Decision
- SFNC Hold
- OCUL Strong Buy
- Analyst Count
- SFNC 4
- OCUL 7
- Target Price
- SFNC $22.50
- OCUL $17.33
- AVG Volume (30 Days)
- SFNC 2.1M
- OCUL 2.0M
- Earning Date
- SFNC 07-17-2025
- OCUL 08-05-2025
- Dividend Yield
- SFNC 4.47%
- OCUL N/A
- EPS Growth
- SFNC 6.65
- OCUL N/A
- EPS
- SFNC 1.27
- OCUL N/A
- Revenue
- SFNC $742,875,000.00
- OCUL $59,647,000.00
- Revenue This Year
- SFNC $26.70
- OCUL N/A
- Revenue Next Year
- SFNC $7.88
- OCUL $20.85
- P/E Ratio
- SFNC $15.00
- OCUL N/A
- Revenue Growth
- SFNC 2.18
- OCUL N/A
- 52 Week Low
- SFNC $17.20
- OCUL $5.79
- 52 Week High
- SFNC $25.95
- OCUL $12.35
- Technical
- Relative Strength Index (RSI)
- SFNC 41.26
- OCUL 68.93
- Support Level
- SFNC $19.51
- OCUL $11.76
- Resistance Level
- SFNC $19.98
- OCUL $12.35
- Average True Range (ATR)
- SFNC 0.52
- OCUL 0.45
- MACD
- SFNC -0.12
- OCUL -0.07
- Stochastic Oscillator
- SFNC 16.63
- OCUL 69.93
About SFNC Simmons First National Corporation
Simmons First National Corp is a financial holding company. The company through its subsidiaries is engaged in providing banking services including consumer, real estate and commercial loans, checking, savings and time deposits. The company's loan portfolio comprises construction, single-family residential and commercial loans; non-real estate loans, nonaccrual and past due loans; and credit card loans, student loans and other consumer loans. It also offers various products and services such as trust services, investments, agricultural finance lending, equipment lending, insurance, consumer finance and small business administration lending. The business activity of the firm is functioned through the region of the United States.
About OCUL Ocular Therapeutix Inc.
Ocular Therapeutix Inc is a biotechnology company that specializes in therapies for diseases and conditions of the eye. The company uses its proprietary hydrogel platform technology to deliver therapeutic agents to the eye. Its pipeline consists of eye medication that aims to overcome the limitations of current eye-drop-based therapies for ophthalmic diseases and conditions. Its pipeline product includes Dextenza, OTX-TIC, OTX-TKI, and OTX-IVT.